Health Care REIT (HCN) - FREE Research Report

Herman Charles J Jr who is EVP & Chief Investment Officer at Health Care REIT sold 833 shares at $62.47 on Oct. 11, 2013. Following this transaction, the EVP & Chief Investment Officer owned 42,239 shares meaning that the stake was reduced by 1.93% with the 833 share transaction.

The shares most recently traded at $62.04, down $0.43, or 0.7% since the insider transaction. Historical insider transactions for Health Care REIT go as follows:

  • 12-Week # shares sold: 250
  • 24-Week # shares sold: 12,351

The average volume for Health Care REIT has been 1.8 million shares per day over the past 30 days. Health Care REIT has a market cap of $18.1 billion and is part of the financial sector and real estate industry. Shares are up 2.9% year to date as of the close of trading on Friday.

Health Care REIT, Inc. is an independent equity real estate investment trust. The firm engages in acquiring, planning, developing, managing, repositioning and monetizing of real estate assets. It primarily invests in the real estate markets of the United States. The stock currently has a dividend yield of 4.85%. The company has a P/E ratio of 81.9. Currently there are 6 analysts that rate Health Care REIT a buy, 2 analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HCN - FREE

TheStreet Quant Ratings rates Health Care REIT as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations and growth in earnings per share. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, disappointing return on equity and poor profit margins. Get the full Health Care REIT Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Biotech Movers: Jazz Shares Lower Amid Notes Offering

Blame the Millennials: Cramer's 'Mad Money' Recap (Wednesday 8/9/17)

Biotech Movers: Paratek, Opko, Endo

Insiders Are Loading Up on GE, Twilio & More

Ford Motor, Constellation Brands, Cypress Semiconductor: 'Mad Money' Lightning Round